Elacestrant Market Size, Forecast, and Emerging Insight

أضاف وظيفة جديدة Health

2025-01-13 10:42:31 -

Elacestrant Market Size, Forecast, and Emerging Insight – 2032

Elacestrant, a selective estrogen receptor degrader (SERD), is rapidly emerging as a promising treatment option in the oncology market, particularly for hormone receptor-positive (HR+), HER2-negative breast cancer. As a targeted therapy, Elacestrant works by binding to estrogen receptors and promoting their degradation, which helps inhibit cancer cell growth. This article...

0 التعليقات 0 المشاركات 19 مشاهدة 0 معاينة